Based on its complexity, heterogenicity and histological features, it has been classified into hormone-receptor-positive, human epidermal growth factor receptor-2 overexpressing (HER2+) and triple-negative breast cancer (TNBC) [34]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.